Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL25313166

COC(=O)c1ccc(N2CC3(CCNCC3)C2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.49
USP2 O75604 9/20 0.48
CYP3A4 P08684 8/20 0.48
HSD17B10 Q99714 7/20 0.48
ALDH1A1 P00352 7/20 0.48
MAPK1 P28482 6/20 0.48
CYP2D6 P10635 6/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
CYP1A2 P05177 4/20 0.48
TP53 P04637 3/20 0.48
HPGD P15428 2/20 0.48
CYP2C19 P33261 5/20 0.46
CYP2C9 P11712 4/20 0.44
HIF1A Q16665 3/20 0.44
OPRD1 P41143 1/20 0.41
OPRM1 P35372 1/20 0.40
OPRL1 P41146 1/20 0.40
GABRD O14764 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25900955 0.91 TSHR (0.54) TSHRUSP2CYP3A4HSD17B10ALDH1A1
Trifluoroacetic Acid SCHEMBL6132228 0.81 ALDH1A1 (0.51) TSHRUSP2HSD17B10ALDH1A1OPRD1
SCHEMBL20897571 0.79 ALDH1A1 (0.54) TSHRUSP2CYP3A4HSD17B10ALDH1A1
SCHEMBL20897460 0.79 ALDH1A1 (0.57) TSHRUSP2CYP3A4HSD17B10ALDH1A1
SCHEMBL30463893 0.78 TSHR (0.65) TSHRUSP2CYP3A4HSD17B10ALDH1A1
SCHEMBL20897443 0.75 ALDH1A1 (0.60) TSHRUSP2CYP3A4HSD17B10ALDH1A1
Trifluoroacetic Acid SCHEMBL3118202 0.75 CYP3A4 (0.65) TSHRUSP2CYP3A4HSD17B10ALDH1A1
SCHEMBL25313895 0.74 CYP3A4 (0.58) TSHRUSP2CYP3A4HSD17B10ALDH1A1
SCHEMBL532602 0.73 ALDH1A1 (0.65) TSHRUSP2HSD17B10ALDH1A1SMN1; SMN2
SCHEMBL25933613 0.73 MAPK1 (0.44) TSHRUSP2CYP3A4HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066359-A1 SOMATOSTATIN RECEPTOR SUBTYPE 5 ANTAGONISTS, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2025-02-27 US disclosed
WO-2023125486-A1 SOMATOSTATIN RECEPTOR SUBTYPE 5 ANTAGONISTS, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF 中国科学院上海药物研究所 2023-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066359-A1 SOMATOSTATIN RECEPTOR SUBTYPE 5 ANTAGONISTS, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF SSTR5, SSTR2, SSTR3 TSHR 40/4885USP2 2879/4885CYP3A4 2559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.